Page 93 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰Ｘ機遇與未來大會手冊

劉慧康 博士 Hui-Kang Liu, PhD

◼ Position/Affiliation/E-mail
Position/Affiliation:

Associate Research Fellow, Division of Basic Chinese Medicine, National
Research Institute of Chinese Medicine (NRICM), Ministry of Health and
Welfare;
Adjunct Associate Professor, Ph. D. Program in the Clinical Drug Development of Herbal

Medicine, Taipei Medical University, Taipei, Taiwan.
E-mail: hk.liu@nricm.edu.tw

◼ Biography

Dr. Hui-Kang (Glenn) Liu is an Associate Research Fellow at the National Research Institute
of Chinese Medicine, Ministry of Health and Welfare, Taiwan, and Adjunct Associate Professor
in the Ph.D. Program in Clinical Drug Development of Herbal Medicine at Taipei Medical
University. He earned his B.Sc. in Food Science from Tunghai University, Taiwan, and

completed both his M.Sc. and Ph.D. in Biomedical Sciences at the University of Ulster, UK,
followed by postdoctoral training in Molecular Physiology at the University of Dundee, UK.
Dr. Liu’s research focuses on natural products and traditional Chinese medicine (TCM) for
the treatment of metabolic and neurodegenerative diseases. His interests include developing

GLP-1 receptor agonists and incretin modulators from medicinal plants, investigating the
comorbidity mechanisms of type 2 diabetes and Alzheimer’s disease, and exploring medicinal
food materials for obesity, fatty liver, and diabetes-related complications.
He has published extensively in international journals such as Phytomedicine,

Pharmacological Research, Journal of Natural Products, Food & Function, and British Journal
of Pharmacology. His contributions include the discovery of boschnaloside from Boschniakia
rossica as a GLP-1 receptor activator, and characterization of carotenoids from Momordica
cochinchinensis (Gac fruit) as GLP-1 secretagogues. Dr. Liu also holds patents related to

botanical therapeutics for metabolic and neurological disorders. He is currently an editorial
board member of the World Journal of Gastroenterology.

71